Tag | Content |
---|
EnhancerAtlas ID | HS149-00968 |
Organism | Homo sapiens |
Tissue/cell | NKC |
Coordinate | chr5:169695490-169697720 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SPI1 | MA0080.4 | chr5:169696081-169696095 | CACTTCCTCATTTT | - | 6.59 |
|
| Number of super-enhancer constituents: 27 | ID | Coordinate | Tissue/cell |
SE_09249 | chr5:169692329-169699770 | CD14 | SE_11928 | chr5:169693117-169698576 | CD3 | SE_13625 | chr5:169695207-169697196 | CD34_Primary_RO01536 | SE_13625 | chr5:169697481-169699448 | CD34_Primary_RO01536 | SE_14332 | chr5:169695525-169697440 | CD34_Primary_RO01549 | SE_14677 | chr5:169692098-169698469 | CD4_Memory_Primary_7pool | SE_16469 | chr5:169695478-169698597 | CD4_Naive_Primary_8pool | SE_16883 | chr5:169693044-169697091 | CD4p_CD225int_CD127p_Tmem | SE_16883 | chr5:169697234-169698419 | CD4p_CD225int_CD127p_Tmem | SE_17361 | chr5:169692097-169727706 | CD4p_CD25-_CD45RAp_Naive | SE_17798 | chr5:169692373-169726573 | CD4p_CD25-_CD45ROp_Memory | SE_18294 | chr5:169686169-169728191 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19153 | chr5:169692401-169699407 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20508 | chr5:169693213-169698312 | CD56 | SE_20940 | chr5:169692446-169698603 | CD8_Memory_7pool | SE_22165 | chr5:169693740-169697944 | CD8_Naive_8pool | SE_22357 | chr5:169692276-169699719 | CD8_primiary | SE_26492 | chr5:169695900-169697860 | Duodenum_Smooth_Muscle | SE_31065 | chr5:169693167-169696976 | Fetal_Thymus | SE_50346 | chr5:169693176-169696937 | Sigmoid_Colon | SE_50346 | chr5:169697264-169699447 | Sigmoid_Colon | SE_53112 | chr5:169695423-169696995 | Small_Intestine | SE_53112 | chr5:169697337-169698397 | Small_Intestine | SE_53694 | chr5:169692281-169699539 | Spleen | SE_55128 | chr5:169695187-169696847 | Thymus | SE_60036 | chr5:169645510-169707775 | Ly4 | SE_62507 | chr5:169687675-169764976 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr5 | 169695824 | 169696287 | chr5 | 169696407 | 169697161 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I170265 | chr5 | 169692314 | 169699635 |
|
Enhancer Sequence | GGAAACACAA GGTTATTAAA GTGAAAGGGG AGTATCGGCC AAGCTCAGGG GTCTCCAGGA 60 ACAGATATGC AGCTCGGGGC ACCGGGGGTG CATGATCCTT GACCCCCAGG CCCACATGAG 120 CCCCAGCCAC GGGGAGACCC AGCCTGGATC TCACCCACCC CTCCCTGCCC ATTTTTTCTG 180 TCCTAGTTTG TGTCACTCTC CTTATACACA GGCTCAGCTT TCTTTGCATT TCACAGGAAT 240 AGGTATTTAT CAGAGATTTT GCCAATCAAG AAAGGCCTCT TTGTAACCAG CTCAGCCAGA 300 ACTGGAAGGG AGGATTTTCA GACAATTTTG TAAGAAGTAA ACATACGCAT ACCTCTGTAT 360 GCAGACACAC AGATATACAC ATGTGCACAC ATGCATGCAC ACACATGCAT ATATATGCAC 420 ACACCTGCAT ACACAGAGAC ACGAGTGCAC ACAGACACAC ACACATGCCA AAAATCTCAC 480 AGGCACACCC AGCTGCCTGT GCAGGGTGAA GTCAGCTCTC ACTGCCATAG GGATCTTGTT 540 CTGTCTGCCC TTCCTTCCCC TCTCCAGTGT CCTGGGCTAT CTCCTCCCTG ACACTTCCTC 600 ATTTTGCTCA TCTCTTCCCA TAAAGGGAGG AGCTGATCAC CAACTTCTGT TACCAGACCA 660 CAGACTCTTA AGTGGAAGCT AGATTTGCCT CGAGCAGAAA CTCACATTAT CTGGGCAGAA 720 ACTCACATTA TCCACATCTC CACGGAAGTG TCCCTAGGCC AGGTTGACAG GCTGGCAATT 780 TCCTACCCCT TTGACAGGGA AAGGCCAGGA CAAGACCATC AAGCAAGAGG GGTGAGTGGG 840 TAGGGCCTCC TTACGCTTTG TGCCCTGGGT GCCTCTCTTG CCCGACTCTA GTCCCAGCCT 900 TGGGGAGGTG CAGCTCTTCC ACAGGGAAAA GGGTAGGAGC AAGGCCCAGC CTGATCTAAT 960 TCCACCCTGC TCCACCCGCA CTGGCCATCT CTCAGCTTCT CTAATAGGCC ATGCTCCTTT 1020 GAGCCTCAGG GCCTTTGCAC AGCCATTTCT ACTGCTCCAA ATGTTCTTCC CTTACCACAT 1080 CCATTTCCAC TTGGCCAACT TGTATTTATC CTTTAACCTT GGTTTAATAT CACAGCTTAA 1140 AGATACACCC TCAGGCAAAC GCTCCAGCCT CATCTGTGCT TGTCTTCGTG CCTCTGTATC 1200 ACGGTTTCAC CAAGTAACCT CATGGCTCAT TTGTTGGAGG GTGCGTCACC TGCCAGACTG 1260 TCAGTCCCTT GGCGAGGGCT GTCTTATTCA CTCTGTATCT TAATGACTGG CACACACAAG 1320 GCACTCAACA ACTGACTCAT CCATTGCTTT TCCGGACCTC CACTTCCCTG TATATGAAAC 1380 AGACTTGATC ATGGTTGTCC TTATTACACA GATGTTTAAA AACCACCATG AGATATTGAG 1440 ACAGCATTTT GTGAAAGGGC TTTAAAATGG AAATGGGTTA TACCGCATAA AGGATTAAAT 1500 GGTATTCGTT TTTTGTGGTA CTGACCTTCA ATTTTCAGCG TACTCTCTGA AAGTATATTA 1560 TTTAAGAATA TATTTGTTTA TTTTCTGTCA ACACCACTAC TAGAATGTAA GCCCCAGGAG 1620 GCAGGGGCTA TTTCTTCTTT CCTGATCATT TCTAAGCACT GAGAATGGGG CCTGGGCTCC 1680 CAGCAGATCA ACAATGTTTG TTGAATGAAT GGAGAGAGAA GTGGGCTAAA AGGACAGATA 1740 GACAATAAAA ATCGTAAACA CCATCTAATA TTTTTTAAAG TTATAGTCAA ACCCTACTCA 1800 ATATCTTCAT GTTTATTCTA GCATAATAAT GCCATGTAAC TATAATTTGG TCAAAAGATG 1860 GGGAGGAACA GGAAAGTACT CTTGGAGTAC CTGAGTAAAC TGCAGAATGA GTTGAAACTG 1920 CCAAATAGCC TTAGGTGGTA GTTCAATGCT GATATCAGCC ACCATAGGCA AGAATTGGTT 1980 GCAGTCTTAG TAGTCCTCAC AGGAAACCTA TGTGGTCTGT ACATTTATTA TCCTATTTCA 2040 CAGATGAGGA AATTGAGGCC CAGAGAGACA GAGTTACTTG TACAAAGCCA CATAGCTGTT 2100 AAGAAGCCGA GCAGATATCG AGACCCAGAG CTTTCTGCTA CATGGGCAAG CTGGGGCATC 2160 AGCCTTCCAT GCAGCAGTGG CGAGCTTGCC TTTGGGCTGC TCGGGCCAGA AAATCCGGAA 2220 ACGGGCCCTT 2230
|